Cargando…
The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
BACKGROUND & OBJECTIVE: High prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus results in deleterious complications and morbidities related to both diseases. Thus, we aimed to investigate dietary and anthropometric risk factors for progression of N...
Autores principales: | Soltanieh, Samira, Salavatizadeh, Marieh, Poustchi, Hossein, Yari, Zahra, Mansour, Asieh, Khamseh, Mohammad E., Malek, Mojtaba, Alaei-Shahmiri, Fariba, Hekmatdoost, Azita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006473/ https://www.ncbi.nlm.nih.gov/pubmed/36915483 http://dx.doi.org/10.1016/j.heliyon.2023.e13983 |
Ejemplares similares
-
Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes
por: Salavatizadeh, Marieh, et al.
Publicado: (2022) -
Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Salavatizadeh, Marieh, et al.
Publicado: (2023) -
The association of dietary approach to stop hypertension (DASH) diet with hospitalization risk in patients with COVID-19
por: Zamanian, Ali, et al.
Publicado: (2023) -
Relationship Between Dairy Intake and Hospitalization Risk and Disease Severity in Patients With COVID-19
por: Abbas-Hashemi, Seyed Ali, et al.
Publicado: (2023) -
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)